Hachem, M., Haddad, F., Jabbour, E., Issa, G. C., Sasaki, K., Nasr, L. F., Senapati, J., Goulart, H., Bataller, A., Kadia, T. M., Stevens, K., Castellano, J., Montalban-Bravo, G., Pemmaraju, N., Dellasala, S., Kantarjian, H. M. (2026). Phase II trial of asciminib for newly diagnosed chronic myeloid leukemia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6589